Scandinavian Biolabs ApS: Financial statements 2025
CVR: 41170514
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Scandinavian Biolabs ApS (CVR 41170514) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -13,841,560 and a net result of DKK -25,270,973 compared with DKK -8,773,342 the year before. Equity in the 2025 report amounted to DKK 31,549,921. The solvency ratio was 70.8%. The company had 18 employees in the financial year.
- Gross Profit
- DKK -13,841,560
- Profit/Loss
- DKK -25,270,973
- Equity
- DKK 31,549,921
- Total Assets
- DKK 44,574,096
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -13.8M | -25.3M | 31.5M | 18 |
| 2024 | - | -519K | -8.8M | 17.6M | 15 |
| 2023 | - | 5.1M | -1.4M | -1.3M | 22 |
| 2022 | - | 1.6M | -2.5M | -5.9M | 19 |
| 2021 | - | -1.9M | -4.6M | -3.4M | 12 |
Official annual report
How creditworthy is Scandinavian Biolabs ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of September 9, 2025, Samuel Meeker Kaplan has joined the board of directors of Scandinavian Biolabs ApS.
As of September 9, 2025, Anders Reckendorff is registered as an owner of Scandinavian Biolabs ApS.
Scandinavian Biolabs ApS has published its annual report for 2024. Gross profit came to DKK -518,948, and the net result was DKK -8,773,342.
About Scandinavian Biolabs ApS
Scandinavian Biolabs ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med parfumerivarer og kosmetik. The management consists of Niels Valdemar Lundsgaard Konradi. The board consists of Mitesh Jatania (chair), Anders Reckendorff, Pascar Paw Paramasivam and Samuel Meeker Kaplan. The company's owners include Niels Valdemar Lundsgaard Konradi, Anders Reckendorff and BLAZAR ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -13,841,560 and a net result of DKK -25,270,973 compared with DKK -8,773,342 the year before. Equity in the 2025 report amounted to DKK 31,549,921.